MARIAN GEORGIEV: Open Payments
NPI 1407099096 · READING, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$549 in 23 payments from 6 companies in 2025. Trend: 2023 $355 · 2024 $309 · 2025 $549
Food & beverage: $431Education: $118
| Company | Payments | Amount |
|---|---|---|
| Teva Pharmaceuticals USA, Inc. | 6 | $206 |
| Otsuka America Pharmaceutical, Inc. | 10 | $176 |
| E.R. Squibb & Sons, L.L.C. | 3 | $72 |
| Janssen Pharmaceuticals, Inc | 2 | $51 |
| Neurocrine BioSciences, Inc. | 1 | $22 |
| Alkermes, Inc. | 1 | $22 |
Products named: UZEDY, REXULTI, ABILIFY ASIMTUFII, COBENFY, SPRAVATO, INGREZZA, LYBALVI, INVEGA SUSTENNA.
Industry payments across PA — which companies pay providers there.
